The Use of Bilateral Internal Mammary Arteries for Coronary Revascularization in Patients with COPD: Is It a Good Idea?
AbstractBackground: The use of bilateral internal mammary arteries (BIMA) is limited worldwide, especially in patients with chronic obstructive pulmonary disease (COPD). Thus, we assessed the safety of the use of BIMA in COPD patients.
Methods: From cohorts of 8846 patients operated on at our center for primary isolated multi-vessel coronary bypass operations between 2002 and 2012, we studied two propensity-matched groups of patients with COPD who received either single internal mammary artery and saphenous vein grafts (SIMA group: 137 patients) or exclusively BIMA (BIMA group: 137 patients). Preoperative data were similar regarding age (63.59 ± 10.62 versus 65.55 ± 9.61 years;
P = .10), body mass index (BMI) (28.6 ± 4.71 versus 28.42 ± 3.86 kg/m2; P = .72), diabetes mellitus (32% versus 27%; P = .08), EuroSCORE (4.34 ± 2.23 versus 4.8 ± 2.52; P = .09) and ejection fraction (58.7 ± 13.08% versus 60.29 ± 14.13%; P = .32).
Results: No significant differences were noticed between the two groups regarding the number of peripheral anastomoses (3.07 ± 0.77 versus 3.06 ± 0.85; P = .90), total operation time (192.17 ± 43.06 versus 200.63 ± 39.24 min; P = .08), postoperative stroke (0.7% versus 0%; P = .29), myocardial infarction (2.92% versus 3.6%; P = .81), reintubation (2.9% versus 4.4%; P = .66), reexploration (0.7% versus 2.2%;
P = .32), deep sternal wound infection (2.9% versus 3.6%;
P = .81) and 30-day mortality (2.2% versus 2.9%; P = .77). However, postoperative blood loss (726.1 ± 468.35 versus 907 ± 890.58 mL; P = .03) was higher in the BIMA group.
Conclusion: COPD patients can benefit from coronary artery revascularization with BIMA; however, postoperative blood loss can be higher using this technique.
Albert A, Sergeant P, Florath I, Ismael M, Rosendahl U, Ennker J. 2011. Process review of a departmental change from conventional coronary artery bypass grafting to totally arterial coronary artery bypass and its effects on the incidence and severity of postoperative stroke. Heart Surg Forum 14:E73-80.
Barbut D, Yao FF, Lo Y, et al. 1997. Determination of size of aortic emboli and embolic load during coronary artery bypass grafting. Ann Thorac Surg 63:1262-7.
Boschetto P, Beghe B, Fabbri LM, Ceconi C. 2012. Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice. Respirology 17:422-31.
Bridgewater B, Keogh B. 2008. On behalf of the Society for Cardiothoracic Surgery in Great Britain & Ireland. Sixth National Adult Cardiac Surgical Database Report.
Clark RE. 1994. Definitions of terms of The Society of Thoracic Surgeons National Cardiac Surgery Database. Ann Thorac Surg 58:271-3.
Daganou M, Dimopoulou I, Michalopoulos N, et al. 1998. Respiratory complications after coronary artery bypass surgery with unilateral or bilateral internal mammary artery grafting. Chest 113:1285-9.
De Paulis R, de Notaris S, Scaffa R et al. 2005. The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: The role of skeletonization. J Thorac Cardiovasc Surg 129:36-43.
Dorman MJ, Kurlansky PA, Traad EA, Galbut DL, Zucker M, Ebra G. 2012. Bilateral internal mammary artery grafting enhances survival in diabetic patients: a 30-year follow-up of propensity score-matched cohorts. Circulation. 126:2935-42.
Farinas JM, Carrier M, Hébert Y, et al. 1999. Comparison of long-term clinical results of double versus single internal mammary artery bypass grafting. Ann Thorac Surg 67:466-70.
Fuster RG, Argudo JA, Albarova OG. 2006. Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting. Eur J Cardiothorac Surg 29:202-9.
Gardner SC, Grunwald GK, Rumsfeld JS, et al. 2001. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 72:2033-7.
Geraci JM, Rosen AK, Ash AS, McNiff KJ, Moskowitz MA. 1993. Predicting the occurrence of adverse events after coronary artery bypass surgery. Ann Intern Med 118:18-24.
Grover FL, Johnson RR, Marshall G, Hammermeister KE. 1993. Factors predictive of operative mortality among coronary artery bypass subsets. Ann Thorac Surg 56:1296-307.
Güler M, Kirali K, Toker ME, et al. 2001. Different CABG methods in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 71:52-7.
Hannan EL, Wu C, Bennett EV, et al. 2006. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol 47:661-8.
Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. 1992. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 267:234-8.
Itagaki S, Cavallaro P, Adams DH, Chikwe J. 2013. Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1526360 coronary bypass operations. Heart 99:849-53
Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Zucker M, Ebra G. 2010. Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. Ann Thorac Surg 90:101-8.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. 1999. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20:250-78.
Mohammadi S, Dagenais F, Voisine P, et al. 2014. Lessons learned from the use of 1,977 in-situ bilateral internal mammary arteries: a retrospective study. J Cardiothorac Surg 9:1-8.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13.
Online STS Risk Calculator. Available at: http://riskcalc.sts.org. Accessed October 10, 2015.
Roques F, Nashef SA, Michel P, et al. 1999. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816-23.
Shroyer AL, Coombs LP, Peterson ED, et al. 2003. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75:1856-64.
Tabata M, Grab JD, Khalpey Z, et al. 2009. Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database. Circulation 120:935-40.
Tatoulis J. 2013. Total arterial coronary revascularization: patient selection, stenoses, conduits, targets. Ann Cardiothorac Surg 2:499-506.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).